Mannich Curcuminoids as Potent Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Organic Synthesis

Background:

• Curcuminoids are known for their therapeutic potential, but their clinical application is limited by poor bioavailability.
• Novel synthetic routes are needed to develop more potent and effective curcumin analogues.

Purpose of the Study:

• To synthesize novel curcuminoids using a Mannich-3CR/organocatalysed Claisen-Schmidt condensation sequence.
• To evaluate the anti-proliferative activity of these novel curcuminoids against lung adenocarcinoma cell lines (A549 and H1975).
• To investigate the underlying mechanisms of action, including TNFα-induced NF-κB inhibition and autophagy induction.

Main Methods:

• Synthesis of novel curcuminoids via a multi-step reaction sequence.
• Cell viability assays to determine anti-proliferative activity.
• Holographic microscopic imaging for cellular analysis.
• In vivo studies using a xenograft mouse model to assess tumor growth inhibition.

Main Results:

• A series of novel curcuminoids were successfully synthesized for the first time.
• The synthesized analogues demonstrated significant anti-proliferative activity against A549 and H1975 lung cancer cells.
• Tumor necrosis factor-alpha (TNFα)-induced nuclear factor-kappa B (NF-κB) inhibition and autophagy induction correlated with cytotoxic potential.
• The most potent analogue (compound 44) encapsulated in liposomes showed significant tumor growth inhibition in an A549 xenograft model at a low dose.

Conclusions:

• The novel Mannich curcuminoids possess a promising spectrum of anti-cancer activity.
• These compounds exhibit potent anti-proliferative effects and inhibit tumor growth through mechanisms involving NF-κB and autophagy.
• Further preclinical investigations are warranted to explore the therapeutic potential of these novel curcuminoids.